ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated

Also written as “medium dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated”, “high dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated” and “bivalent enterovirus vaccine (Vero cell), inactivated”.

Its studies are mostly in Hand, Foot and Mouth Disease, led by Sinovac Biotech.

Furthest: phase 3, since Dec 4, 20242 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Sinovac Biotech21 open or runningphase 3since Dec 4, 2024Sep 15, 2023none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 15, 2023First study: phase 2 study in Hand, Foot and Mouth DiseaseFirst studyNCT06063057 · 744 enrolled · China
  2. Dec 4, 2024Phase 3 study in Hand, Foot and Mouth DiseaseNCT06734832 · 8,000 planned · China

TargetBeta

A vaccine: it acts on a pathogen, not a human gene.

“low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated”name, by rule

Studies

All 2 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06734832Hand, Foot and Mouth Disease · China3RecruitingNov 30, 20258,000
NCT06063057Hand, Foot and Mouth Disease · China2CompletedDec 19, 2025744

How it is read

Names in the registry

  • “low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated”, 1 entry
  • “medium dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated”, 1 entry
  • “high dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated”, 1 entry
  • “bivalent enterovirus vaccine (Vero cell), inactivated”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.